MedTrace Logo

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

NCT00653588 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2009-03-16

No results posted yet for this study

Summary

The purpose of this study is to compare the effect of 8 weeks of treatment with Rosuvastatin with 8 weeks of treatment with Atorvastatin on low density lipoprotein cholesterol level in subjects with hypercholesterolemia and coronary heart disease (CHD) or at high risk of CHD..

Conditions

Interventions

DRUG

Rosuvastatin

40mg

DRUG

Atorvastatin

80mg

Sponsors & Collaborators

Principal Investigators

  • Dr. Lawrence Leiter · St Michaels hospital, Canada

Study Design

Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2004-09-30

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00653588 on ClinicalTrials.gov